share_log

Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93

Benzinga ·  Nov 1 11:31  · Ratings

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and raises the price target from $92 to $93.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment